Drug intelligence / Profile preview

uMAT-ADSC-exo

Development stage
Preclinical
Lead developer
Shanghai Tenth People's Hospital
Modality
Lipid-based Nanoparticles → Nanoparticles → Drug Delivery Systems
Administration
Parenteral
01

Overview

uMAT-ADSC-exo refers to exosomes derived from adipose-derived stem cells (ADSCs) isolated from uninvolved mesenteric adipose tissue (uMAT) of patients with Crohn's disease. In research contexts, these exosomes are often used as a control or comparator for exosomes derived from "creeping fat" (CrF). Studies have shown that these exosomes contain specific microRNAs, such as miR-132-3p, which regulate lymphatic endothelial cell functions (proliferation, migration, and tube formation) via the RASA1/ERK1/2 signaling pathway. While primarily a research tool to understand the pathophysiology of Crohn's disease and mesenteritis, the study of these vesicles provides insights into potential therapeutic targets for improving lymphatic drainage and alleviating intestinal inflammation.

Other names
uninvolved mesenteric adipose tissue-derived adipose stem cell exosomesuMAT-ADSC-derived exosomes
02

Targets

RASA1 (Ras GTPase-activating protein 1)RAS p21 protein activator 1 (RASA1) mRNAMAPK3 (Mitogen-activated protein kinase 1)

Beyond the preview

Go deeper on uMAT-ADSC-exo.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on uMAT-ADSC-exo.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call